Vor Biopharma Inc [NASDAQ: VOR] gained 19.10% or 11589999.11 points to close at $11590000.0 with a heavy trading volume of 48540533 shares.
It opened the trading session at $0.94, the shares rose to $1.23 and dropped to $0.905, the range by which the price of stock traded the whole day. The daily chart for VOR points out that the company has recorded 22.11% gains over the past six months.
If we look at the average trading volume of 11.59M shares, VOR reached to a volume of 48540533 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Vor Biopharma Inc [VOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VOR shares is $4.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VOR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wedbush have made an estimate for Vor Biopharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 26, 2022. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on April 27, 2022, representing the official price target for Vor Biopharma Inc stock. Previously, the target price had yet another raise to $26, while H.C. Wainwright analysts kept a Buy rating on VOR stock.
The Price to Book ratio for the last quarter was 2.00, with the Price to Cash per share for the same quarter was set at 0.48.
Trading performance analysis for VOR stock
Vor Biopharma Inc [VOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 341.12. With this latest performance, VOR shares gained by 497.18% in over the last four-week period, additionally plugging by 22.11% over the last 6 months – not to mention a drop of -4.50% in the past year of trading.
Vor Biopharma Inc [VOR]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -85.83%, with Return on Assets sitting at -85.83%.
Vor Biopharma Inc [VOR]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VOR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vor Biopharma Inc go to 29.59%.
An analysis of Institutional ownership at Vor Biopharma Inc [VOR]
There are presently around $48.76%, or 71.59% of VOR stock, in the hands of institutional investors. The top three institutional holders of VOR stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 22.75 million shares, which is approximately 33.439%. FMR LLC, holding 7.08 million shares of the stock with an approximate value of $$7.08 million in VOR stocks shares; and FMR LLC, currently with $$6.46 million in VOR stock with ownership which is approximately 9.4917%.
